LJ-2698

DB18018ExperimentalSmall molecule

LJ-2698: Overview.

Mechanism: Pharmacologically active on Adenosine receptor A3
Curator reviewed
Formula / weight: C₁₆H₁₅Cl₂N₅O₂S · 412.29 g/mol (avg)
Also known as: (2r,3r,4s)-2-(2-chloro-6-(3-chlorobenzylamino)-9h-purin-9-yl)tetrahydrothiophene-3,4-diol · 3,4-thiophenediol, 2-(2-chloro-6-(((3-chlorophenyl)methyl)amino)-9h-purin-9-yl)tetrahydro-, (2r,3r,4s)-
Code names: LJ-2698

Resolves to

Compound

Structure

InChIKeyJQUBXCDDRXAMLF-IXPVHAAZSA-NSMILESO[C@@H]1CS[C@H]([C@@H]1O)N1C=NC2=C(NCC3=CC=CC(Cl)=C3)N=C(Cl)N=C12

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with LJ-2698, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.